+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Varicose Veins Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4896016
  • Report
  • June 2020
  • Region: Global
  • 114 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now


  • AngioDynamics, Inc.
  • Eufoton s.r.l.
  • Lumenis Corporation
  • Medtronic Plc
  • Quanta System (El.en.)
  • Syneron Medical Ltd.
  • MORE
The market for varicose veins is majorly driven by factors such as growing preference of the general population for minimally invasive surgeries, rising geriatric population, and the technological advancements in the devices used for this treatment.

It has been found that nearly 23% of the US adults are having varicose veins and it is more common in older women. Varicose veins affect 22 million women and 11 million men between the ages of 40 to 80 years. In the United Kingdom, diagnosis and treatment of varicose veins include a significant part of the surgical workload. In the UK, National Health Service waiting lists suggest that there is still a considerable unmet need which is posing an opportunity for the companies to establish a better market. Also, developing countries such as India and South Africa are also facing issues while dealing with the varicose veins as there are high unmet needs.

However, with the technological advancements and growing focus on the improvised healthcare system, it is believed that the market will witness steady growth over the forecast period in most of the developing nations. In terms of market size, developed regions such as North America and Europe hold the highest share.

Key Market Trends

Laser Ablation Devices to Witness Considerable Growth Over the Forecast Period

Laser Ablation treatment does not include long hospital stays of discomfort during the recovery which is a positive factor for the patients who are being treated for this disease. The disease is treated with various types of treatment including self-treatment. However, with the help of novel technologies, there has been a large use of lasers for the varicose veins.

This new technology of lasers enables the doctors to close off the smaller varicose veins and spider veins. This treatment allows the strong bursts of light onto the vein making affected veins disappear or fade. The use of laser treatment is increasing across the developed nations as people are able to afford the cost of treatment required and there is no needle or incision is needed for this type of treatment. Also, there is a huge competition among the local laser manufacturers that are into the varicose vein lasers. With the upcoming advancements in lasers and the ease of treatment provided by the same, it is expected that the segment will grow in the future.

Furthermore, laser devices are also used widely for the treatment of diseases such as Peripheral Arterial Disease (PAD) which is a risk factor for the occurrence of varicose veins. Hence, it is indicated that the prevalence of PAD is also affecting the growth of laser devices for varicose veins in a positive manner.

North America Dominates the Market

North America holds the largest share of the market studied and it is believed to follow the same trend over the forecast period. The major factors contributing to the growth of this market in North America include the presence of the developed healthcare system in the United States and the presence of companies that allows easier product availability in the market. Furthermore, due to the favorable reimbursement scenario, people across the United States are able to get the treatment with less cost.

Added to that, the rising prevalence of varicose veins is another factor propelling the growth of the market studied. For instance, the prevalence of varicose veins given by the Chicago Vein Institute is around 55% in women and 45% in men across the United States. It has been suggested by the same institute that there are around 40 million people in the United States suffering from varicose veins.

Competitive Landscape

The market for varicose veins treatment is moderately competitive and comprises most of the local players. There are few international companies that are into this business but the overall market is majorly controlled by the local companies in different geographies. With the growing medical devices market, it is believed that more companies will penetrate the market and hold a substantial share over the forecast period.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5


  • AngioDynamics, Inc.
  • Eufoton s.r.l.
  • Lumenis Corporation
  • Medtronic Plc
  • Quanta System (El.en.)
  • Syneron Medical Ltd.
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Preference of Minimally Invasive Surgeries
4.2.2 Technological Advancements in the Devices
4.2.3 Growing Geriatric Population
4.3 Market Restraints
4.3.1 High Cost of the Procedure
4.3.2 Risk Associated with the Vein Surgeries
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Treatment Type
5.1.1 Endovenous Ablation
5.1.2 Injection Sclerotherapy
5.1.3 Surgical Ligation/Stripping
5.2 By Product
5.2.1 Ablation Devices Radiofrequency Ablation Devices Laser Ablation Devices
5.2.2 Venous Closure Products
5.2.3 Surgical Products
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Syneron Medical Ltd.
6.1.2 Medtronic Plc
6.1.3 Lumenis Corporation
6.1.4 Quanta System (El.en.)
6.1.5 Teleflex Incorporated
6.1.6 Energist Ltd. (Energist Medical Group)
6.1.7 Eufoton s.r.l.
6.1.8 Biolitec AG (BioMed Technology Holdings Ltd)
6.1.9 AngioDynamics, Inc.

Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Syneron Medical Ltd.
  • Medtronic Plc
  • Lumenis Corporation
  • Quanta System (El.en.)
  • Teleflex Incorporated
  • Energist Ltd. (Energist Medical Group)
  • Eufoton s.r.l.
  • Biolitec AG (BioMed Technology Holdings Ltd)
  • AngioDynamics, Inc.
Note: Product cover images may vary from those shown
5 of 5